Winning Health Technology Group Co., Ltd. (SHE:300253)
8.32
+0.07 (0.85%)
Mar 27, 2026, 10:15 AM CST
SHE:300253 Market Cap
SHE:300253 has a market cap or net worth of 18.16 billion as of March 26, 2026. Its market cap has decreased by -29.71% in one year.
Market Cap
18.16B
Enterprise Value
18.04B
Revenue
2.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
8.32
Market Cap Chart
Since August 18, 2011, SHE:300253's market cap has increased from 2.30B to 18.16B, an increase of 689.97%. That is a compound annual growth rate of 15.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 18.16B | -6.42% |
| Dec 31, 2025 | 19.41B | 24.79% |
| Dec 31, 2024 | 15.55B | 1.39% |
| Dec 29, 2023 | 15.34B | -30.06% |
| Dec 30, 2022 | 21.93B | -39.02% |
| Dec 31, 2021 | 35.97B | -3.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 358.68B |
| WuXi AppTec | 282.97B |
| Shenzhen Mindray Bio-Medical Electronics | 202.54B |
| Sichuan Biokin Pharmaceutical | 108.64B |
| Winner Medical | 19.14B |
| Autobio Diagnostics | 18.98B |
| Walvax Biotechnology | 18.95B |
| Apeloa Pharmaceutical Co.,Ltd | 18.88B |